| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $687.6M | +14.7% |
| Cost of Revenue | $63.5M | +17.6% |
| R&D Expense | $82.5M | +2.5% |
| SG&A Expense | $61.6M | +3.0% |
| Operating Income | $9.4M | +161.1% |
| Pre-tax Income | $5.0M | -20.6% |
| Income Tax | -$25.4M | -240.3% |
| Net Income | $30.4M | +357.6% |
| EPS (Basic) | $0.40 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.3M | -34.0% |
| Accounts Receivable | $102.2M | +35.4% |
| Current Assets | $196.7M | -0.9% |
| Total Assets | $437.6M | +4.5% |
| Current Liabilities | $60.1M | +61.1% |
| Total Liabilities | $73.4M | +42.0% |
| Stockholders' Equity | $364.2M | -0.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $71.8M | -0.4% |
| Capital Expenditures | $600K | -14.3% |
| Investing Cash Flow | -$29.7M | -0.7% |
| Financing Cash Flow | -$76.5M | -192.0% |
| Free Cash Flow | $71.2M | -0.3% |
| +366.7% |
| EPS (Diluted) | $0.38 | +353.3% |